# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $25 price target.
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Buy and lowers the price target from $20 to $18.
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimat...
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Buy and lowers the price target from $17 to $15.
Oil prices surge on anticipation of increased demand and ongoing supply constraints. Goldman Sachs projects continued demand gr...
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and maintains $25 pri...
CLMT reports Q1 fiscal 2024 sales decline of 3%, beating consensus. Net loss per unit $(0.51) down from $0.23 YoY. Gross profit...
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate ...